Key result
Elevated admission CRP in ACS linked to ~72% higher absolute complication risk versus normal levels.
Why the study?
Do elevated C-reactive protein levels correlate with adverse outcomes in patients with acute coronary syndrome?
Observational (n=100)
No
Do elevated C-reactive protein levels correlate with adverse outcomes in patients with acute coronary syndrome?
Absolute Event Rate: 77.3% vs 5.4%
p-value: p=<0.01
Elevated plasma CRP levels on admission in patients with acute coronary syndrome correlate with a higher risk of adverse outcomes and complications.
No takes yet. Share an insight, caveat, or question.
May aid early risk stratification in ACS; leaves open need for prospective validation before guiding care.
Umamaheshwari et al. (2017) conducted an observational in Acute Coronary Syndrome (n=100). Elevated C-Reactive Protein (CRP) levels (≥ 0.6 mg/dL) vs. Normal CRP levels (< 0.6 mg/dL) was evaluated on Development of complications (including death) (p=<0.01). Elevated C-reactive protein levels (≥ 0.6 mg/dL) on admission in patients with acute coronary syndrome were significantly associated with a higher rate of complications compared to normal levels (77.3% vs 5.4%, p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: